Success Stories: NIW Petition Approved for Clinical Cytogeneticist in Wisconsin in the Field of Human Genetics
Client’s Testimonial:
Thank you for the great news. I got a text message from USCIS about my NIW case 20 mins ago, and I have been trying to find out what that ment when I received your email. [...] I really appreciate your service, and would be willing to be of any assistance. I had recommended your name to a couple of my friends 3-4 weeks back, and will continue to do so.
On April 2, 2015 We Received an EB-2 NIW (National Interest Waiver) Approval (Approval Notice) for a Clinical Cytogeneticist in the Field of Human Genetics
Position at the Time of Case Filing: Clinical Cytogeneticist
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Wisconsin
Approval Notice Date: April 2, 2015
Processing Time: 15 Days (NIW and EB1-A filed on the same day and Premium Processing requested for EB1-A)
The client that North America Immigration Law Group – WeGreened.com had the opportunity to work with in this case was a clinical cytogeneticist from India. His work has focused specifically on identifying and describing the genetic underpinnings of human diseases such as glaucoma, autism, Duchenne Muscular Dystrophy, Angelman Syndrome and the related disease Prader-Willi Syndrome, and ADHD. We successfully demonstrated that his continued employment in the field would benefit those in his field, as well as the citizens of the United States at large. In order for our client’s case to be successful, we submitted extensive documentation proving his highly significant contributions to his field, including 11 peer-reviewed journal articles and numerous conference papers. His publications had been cited at least 169 times at the time we filed the case; nearly all of the citations were by independent researchers around the world, demonstrating that these publications are widely recognized and relied upon in the field. The importance of his work was confirmed in the following quote from an independent recommender, “It is worth noting that academic institutions funded by the United States government have also relied on [client’s] research and expertise by citing his work. For example, [client] published a study about the mutation spectrum of FOXC1 gene and its relationship to Axenfeld-Rieger disease. Shortly thereafter, the U.S.’s National Human Genome Research Institute published an article about missense mutations in which they cited [client’s] study. This is clear evidence that [client’s] research has, and will continue to be, to the benefit of the United States and the scientific community.” Through extensive documentation, we were able to successfully argue that our client would serve the national interest to a significantly greater degree than others with similar education and experience. His NIW petition was approved in 15 days.